The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone

被引：0

作者：

Constance Delaby

Teresa Estellés

Nuole Zhu

Javier Arranz

Isabel Barroeta

María Carmona-Iragui

Ignacio Illán-Gala

Miguel Ángel Santos-Santos

Miren Altuna

Isabel Sala

M. Belén Sánchez-Saudinós

Laura Videla

Sílvia Valldeneu

Andrea Subirana

Mireia Tondo

Francisco Blanco-Vaca

Sylvain Lehmann

Olivia Belbin

Rafael Blesa

Juan Fortea

Alberto Lleó

Daniel Alcolea

机构：

[1] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,Sant Pau Memory Unit, Department of Neurology

[2] Universitat Autònoma de Barcelona,Servei de Bioquímica i Biologia Molecular

[3] IRMB,undefined

[4] INM,undefined

[5] Université de Montpellier,undefined

[6] INSERM,undefined

[7] CHU de Montpellier,undefined

[8] Laboratoire de Biochimie-Protéomique clinique,undefined

[9] Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas,undefined

[10] CIBERNED,undefined

[11] Fundació Catalana Síndrome de Down,undefined

[12] Centre Mèdic Down,undefined

[13] Servei de Bioquímica,undefined

[14] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,undefined

[15] Universitat Autònoma de Barcelona,undefined

[16] Unversitat Autònoma de Barcelona,undefined

[17] Centro de Investigación Biomédica en Red en Diabetes y Enfermedades Metabólicas (CIBERDEM),undefined

来源：

Alzheimer's Research & Therapy | / 14卷

关键词：

Amyloid; Aβ1–40; Aβ1–42; Cerebrospinal fluid; Tau; Biomarkers;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort
Michaela Amft
Marion Ortner
Udo Eichenlaub
Oliver Goldhardt
Janine Diehl-Schmid
Dennis M. Hedderich
Igor Yakushev
Timo Grimmer
Alzheimer's Research & Therapy, 14
[32] Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease
Pottiez, Gwenael
Yang, Li
Stewart, Tessandra
Song, Ning
Aro, Patrick
Galasko, Douglas R.
Quinn, Joseph F.
Peskind, Elaine R.
Shi, Min
Zhang, Jing
JOURNAL OF PROTEOME RESEARCH, 2017, 16 (03) : 1228 - 1238
[33] The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort
Amft, Michaela
Ortner, Marion
Eichenlaub, Udo
Goldhardt, Oliver
Diehl-Schmid, Janine
Hedderich, Dennis M.
Yakushev, Igor
Grimmer, Timo
ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
[34] Is plasma amyloid-β 1-42/1-40 a better biomarker for Alzheimer's disease than AβX-42/X-40?
Klafki, Hans-Wolfgang
Morgado, Barbara
Wirths, Oliver
Jahn, Olaf
Bauer, Chris
Esselmann, Hermann
Schuchhardt, Johannes
Wiltfang, Jens
FLUIDS AND BARRIERS OF THE CNS, 2022, 19 (01)
[35] Preservation of Biomarkers Associated with Alzheimer's Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
Tarkowska, Agata
Furmaga-Jablonska, Wanda
Bogucki, Jacek
Kocki, Janusz
Pluta, Ryszard
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
[36] CSF A1-42, but not p-Tau181, Predicted Progression from Amnestic MCI to Alzheimer's Disease Dementia
Rizzi, Liara
Missiaggia, Luciane
Roriz-Cruz, Matheus
NEUROMOLECULAR MEDICINE, 2018, 20 (04) : 491 - 497
[37] Tau protein, beta-amyloid1-42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
Vranova, Hana Prikrylova
Henykova, Eva
Kaiserova, Michaela
Mensikova, Katerina
Vastik, Miroslav
Mares, Jan
Hlustik, Petr
Zapletalova, Jana
Strnad, Miroslav
Stejskal, David
Kanovsky, Petr
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 343 (1-2) : 120 - 124
[38] Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment
Parnetti, Lucilla
Chiasserini, Davide
Eusebi, Paolo
Giannandrea, David
Bellomo, Gianni
De Carlo, Claudia
Padiglioni, Chiara
Mastrocola, Sara
Lisetti, Viviana
Calabresi, Paolo
JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (01) : 229 - 238
[39] Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)
Vanderstichele, Hugo
Demeyer, Leentje
Janelidze, Shorena
Coart, Els
Stoops, Erik
Mauroo, Kimberley
Herbst, Victor
Francois, Cindy
Hansson, Oskar
ALZHEIMERS RESEARCH & THERAPY, 2017, 9
[40] Ratio Aβ1-42:p-Tau: a Possible Diagnostic Tool in Differentiating Dementias
De Riva, Valentina
Galloni, Elisabetta
Lealini, Barbara
Zarantonello, Giulia
Disco, Caterina
Di Dionisio, Laura
Meligrana, Lucia
Marcon, Michela
Perini, Francesco
CLINICAL LABORATORY, 2019, 65 (05) : 817 - 821

← 1 2 3 4 5 →